Abstract
Preparation of autologous bone marrow-derived mesenchymal stem cells (MSCs) for mesenchymal stem cell therapy for canadians with multiple sclerosis (MESCAMS) trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have